1. Introduction {#sec1-life-10-00095}
===============

In 1986, transposable elements (TEs) were found from *Drosophila melanogaster* that have the ability to adjust their position and replicate in host genome that categorizes into two large classes with different mechanisms \[[@B1-life-10-00095]\]. TEs are abundant in the genome of eukaryotes, which is about approximately from 3% up to 85% in the genome of plants and 50% in mammalian's genome. The discovery on specific function of TE is still ongoing assignments for researchers, however, numerous studies revealed that TE is involved in epigenetics \[[@B2-life-10-00095],[@B3-life-10-00095],[@B4-life-10-00095]\], evolution \[[@B5-life-10-00095],[@B6-life-10-00095],[@B7-life-10-00095],[@B8-life-10-00095],[@B9-life-10-00095]\], and disease \[[@B10-life-10-00095],[@B11-life-10-00095],[@B12-life-10-00095]\]. An interesting fact about class I TE called retrotransposons and evolution is that superfamily of retrotransposon long interspersed nuclear element 1 (LINE1 or L1), short interspersed nuclear element (SINE)-variable number of tandem repeat (VNTR)-*Alu* (SVA), and human endogenous retrovirus K (HERV-K) are active TEs in recent human evolution \[[@B13-life-10-00095],[@B14-life-10-00095],[@B15-life-10-00095],[@B16-life-10-00095],[@B17-life-10-00095]\]. As mentioned earlier, not only in evolution, TE has very close relation with human cancer and disease \[[@B18-life-10-00095],[@B19-life-10-00095],[@B20-life-10-00095],[@B21-life-10-00095],[@B22-life-10-00095],[@B23-life-10-00095],[@B24-life-10-00095],[@B25-life-10-00095],[@B26-life-10-00095],[@B27-life-10-00095],[@B28-life-10-00095],[@B29-life-10-00095]\]. For instance, L1 encodes RNA pol II promoter and this L1 promoter is hypomethylated in tumors of lung, colon, and several types of cancers \[[@B19-life-10-00095]\]. TEs merge into the host genome, and this event has the possibility to provide and create new sequences to gene expression regulators such as microRNAs (miRNA) \[[@B4-life-10-00095],[@B30-life-10-00095],[@B31-life-10-00095],[@B32-life-10-00095],[@B33-life-10-00095],[@B34-life-10-00095],[@B35-life-10-00095],[@B36-life-10-00095],[@B37-life-10-00095],[@B38-life-10-00095]\] and transcription factors (TF) \[[@B39-life-10-00095],[@B40-life-10-00095],[@B41-life-10-00095]\].

In 1993, miRNA was first found in *Caenorhabditis elegans* (*C. elegans*) and it is comprised with 19 to 24 nucleotides of non-coding RNAs which is associated with gene regulations by targeting mRNAs for cleavage or translational inhibition \[[@B42-life-10-00095],[@B43-life-10-00095],[@B44-life-10-00095],[@B45-life-10-00095]\]. The essential function of miRNA is correlated with oncogenesis, immunity, developments, and cell differentiations. Generally, 3′ untranslated region (UTR) is the miRNA binding sites of target mRNA. miRNA recognizes the complementary binding sites of target gene for its seed regions which is approximately 6 nucleotides long in miRNA. Previously, numerous studies have provided the evidence of identification on miRNA derived from TE \[[@B30-life-10-00095],[@B31-life-10-00095],[@B33-life-10-00095],[@B34-life-10-00095],[@B36-life-10-00095]\] and some of the miRNAs derived from TE had a strong correlation with human disease \[[@B46-life-10-00095],[@B47-life-10-00095],[@B48-life-10-00095],[@B49-life-10-00095],[@B50-life-10-00095],[@B51-life-10-00095],[@B52-life-10-00095]\] as well as evolution \[[@B53-life-10-00095],[@B54-life-10-00095],[@B55-life-10-00095],[@B56-life-10-00095],[@B57-life-10-00095]\]. Considering the many substantial aspects of TE, miRNAs derived from TE mimic the functions of TE.

Bioinformatics tools are useful for the initial steps before starting the experiments, which is what understanding the primary information on what the study will be about. In the case of TE, analyzing the sequences and predicting structure of TE is important considering the function of TE. A TE-based database called 'Repeatmasker' provides the proportion of each type of TEs among diverse species \[[@B15-life-10-00095]\]. Additionally, there are more of TE related bioinformatics tools and databases that determines which TE has merged into the target sequences, however, TE-based databases and programs are still limited \[[@B58-life-10-00095],[@B59-life-10-00095],[@B60-life-10-00095],[@B61-life-10-00095]\]. In contrast with TE, numerous miRNA-based databases provide basic information about miRNA, miRNA related cancer, target genes, TFs, and so on \[[@B60-life-10-00095],[@B62-life-10-00095],[@B63-life-10-00095],[@B64-life-10-00095],[@B65-life-10-00095],[@B66-life-10-00095],[@B67-life-10-00095]\].

In this study, evolution as well as human disease-related miRNAs derived from TE were examined through published research papers. Those determined miRNAs derived from TE were analyzed by using several bioinformatics tools to provide fundamental information of miRNAs derived from TE.

2. Bioinformatics Analysis of Transposable Elements {#sec2-life-10-00095}
===================================================

The distribution of TEs in various species (human, chimpanzee, gorilla, orangutan, gibbon, macaque, rhesus, marmoset, mouse, horse, cow, cat, dog, chicken, zebrafish, and *C. elegans*) were verified by RepeatMasker Genomic Datasets \[[@B15-life-10-00095]\]. The species that are examined for whole genome sequencing are listed in both UCSC genome browser and RepeatMasker \[[@B15-life-10-00095],[@B60-life-10-00095]\]. [Table 1](#life-10-00095-t001){ref-type="table"} shows the percentage of which TE is or not include in the genome. After the name of the superfamily element such as SINE, LINE, and long terminal repeats (LTR), the specific name of the element is given. The 'other' after the superfamily elements are representing the unspecified elements. The primates, including humans and the other seven of the species, are reasonably chosen to present the percentage of each TEs for evolutionary aspects.

Chicken had the lowest percentage of TEs in the genome (9.3%), and orangutan had the highest percentage of TEs in the genome (48.5%). From primates to mammalians (human, chimpanzee, gorilla, orangutan, gibbon, macaque, rhesus, marmoset, mouse, horse, cow, cat, and dog), variation of TE is well spread out in each species genome, excluding SVA element. SVA element was exclusive in humans. *C. elegans* is another species with the lowest percentage of TE in the genome (9%) and few of the TEs were included (LINE-CR1, LTE-other, DNA-TcMar, DNA-hAT, and DNA-other). Zebrafish is representing species of fish in this table and zebrafish contains the highest percentage of DNA transposons-other (19.6%).

3. Selection of Microrna Related Papers and Bioinformatic Analyses of Transposable Element-Derived microRNAs {#sec3-life-10-00095}
============================================================================================================

miRNAs related with keywords of 'evolution and primates' and 'human disease and cancer' were searched from National Center for Biotechnology Information (NCBI)-PubMed database \[[@B68-life-10-00095]\] and google scholar \[[@B69-life-10-00095]\] ([Figure 1](#life-10-00095-f001){ref-type="fig"}). Each paper contained numerous miRNAs and the information of miRNAs were examined from miRbase v22.1 (<http://www.mirbase.org>) \[[@B66-life-10-00095]\]. Then each miRNA was localized in human genome (GRCh38) by UCSC Genome Browser (<http://genome.ucsc.edu>) \[[@B60-life-10-00095]\].

To determine miRNAs derived from TE from human disease and cancer and evolution and primate-related miRNAs, a total of 41 papers were selected from NCBI-PubMed and google scholar with 31 studies on human disease and cancer and 10 studies on evolution and primate-related miRNAs. MiRNAs derived from TE are fully and partially derived from TE, and some of the miRNAs derived from TE share more than one TEs in the sequence.

4. Bioinformatic Analyses of Evolution Related Transposable Element-Derived microRNAs {#sec4-life-10-00095}
=====================================================================================

The evolution and primate related miRNAs derived from TE from 10 studies were then localized in UCSC genome browser to check the location in the human genome and which type of TE that miRNAs are derived from ([Table 2](#life-10-00095-t002){ref-type="table"}). From a total of 51 miRNAs derived from TE related with evolution and primates, 16 miRNAs were derived from LINE family, 19 from SINE, 3 from LTR, and 15 miRNAs were derived from DNA transposon. Ten of the miRNAs derived from TE were derived from more than one TEs, and interestingly, hsa-miR-548a-2 and hsa-miR-619 are derived from different types of TEs. For instance, hsa-miR-548a-2 is derived from two LTR16A2 at the terminal of miRNA and one DNA transposon MADE1 is in the middle and hsa-miR-619 has one of each L1MC4 and AluSz6.

From a total of 51 evolution and primate-related miRNAs derived from TE, 21 of miRNAs derived from TE with different type of TEs were chosen for further bioinformatics analysis. The evolution and primate related miRNAs derived from TE were analyzed by ECR browser to briefly check the conservation in chimpanzee, rhesus, mouse, cow, dog, chicken, and zebrafish \[[@B72-life-10-00095]\]. Additionally, the structure of each 21 miRNAs derived from TE were predicted by RNAfold webserver which generates the structure of minimum free energy (MFE) contributed by secondary structure of RNA sequences \[[@B73-life-10-00095]\]. The strong base-pairing probability shows in color red with value close to 1 and weak base-pairing probability shows in color blue with value close to 0.

From the numerically ordered list of evolution and primate related miRNAs derived from TE, one of each miRNA was selected from miRNAs derived from the same TE family (hsa-miRNA-28, -130a, -151b, -224, -302e, -320d-1, -342, -378b, -378e, -450b, -513a-1, -544a, -548a-2, -619, -1202, -1261, -1268a, -1302-1, -1303, -1972-1, -3118-3) to examine the conservation throughout human, chimpanzee, rhesus, mouse, cow, dog, chicken and zebrafish ([Figure 2](#life-10-00095-f002){ref-type="fig"}). Amongst the 21 of analyzed evolution and primate related miRNAs derived from TE, hsa-miRNA-151b (chr14: 100,109,419-100,109,514) and -342 (chr14: 100,109,655-100,109,753) are located near each other, however, they do not share the same TE family. All 21 of miRNAs derived from TE were not conserved from chicken and zebrafish and hsa-miRNA-28, -224, and -544a was conserved from chimpanzee, rhesus, mouse, cow and dog, hsa-miRNA-342, -302e, -378b, and -378e was conserved in primates but partially conserved from mouse, cow and dog. Hsa-miRNA-1202 and -3118-3 showed conservation only in chimpanzee and hsa-miRNA-548a-2 and -619 showed conservation only in rhesus monkey. Hsa-miRNA-320d-1, -1261, 1268a, -1302-1, -1303 and -1972-1 shows conservation in primates. Strangely, most of miRNAs derived from TE were well conserved in chimpanzee, however, hsa-miRNA-548a-2 was not conserved in chimpanzee, hsa-miRNA-450b and -619 was partially conserved in chimpanzee, and hsa-miRNA-130a, -1202, -1302-1, and -3118-3 was not conserved in rhesus monkey. Hsa-miRNA-513a-1 was not found in mouse genome.

The secondary structure of 21 of evolution and primate related miRNAs derived from TE were predicted by RNAfold webserver \[[@B73-life-10-00095]\]. Almost all the MFE structure of miRNAs derived from TE had strong base-pairing MFE values, with the exception of hsa-miRNA-1202 which shows weakest MFE structure.

5. Bioinformatic Analyses of Human Diseases Related Transposable Element-Derived microRNAs {#sec5-life-10-00095}
==========================================================================================

The human disease and cancer related miRNAs derived from TE from 31 studies were then localized in the UCSC genome browser to check the location in the human genome and which type of TE that miRNAs are derived from ([Table 3](#life-10-00095-t003){ref-type="table"}). As mentioned previously, miRNAs derived from TE are not only derived from one TE, however, it could be derived from more than one TE with different families. From a total of 34 human diseases and cancer-related miRNAs derived from TE, 16 miRNAs were derived from LINE, 6 from SINE, 2 from LTR, and 10 miRNAs were derived from DNA transposons. Unlike evolution and primate related miRNAs derived from TE which share two types of TEs in one miRNA, no more than one TE type share miRNA from human disease and cancer related miRNAs but 7 out of 34 miRNAs derived from TE share more than one same TE family shares miRNAs derived from TE.

The database TransmiR v2.0 was used to predict the correlation of miRNAs and TFs \[[@B67-life-10-00095]\]. From all the list of the human disease uploaded in TransmiR database, three diseases Mesothelioma, Atherosclerosis and Neuroblastoma related miRNAs and TF were found ([Figure 3](#life-10-00095-f003){ref-type="fig"}). Hsa-miRNA-625 is one of the Mesothelioma-related miRNA and it is activated by EGR1, PGR, and ESR1 TFs. The evidence level of EGR1 and ESR1 is level 2 and it is stricter than level 1 TF PGR. Atherosclerosis related miRNAs derived from TE is hsa-miRNA-342 and it is activated by ESR1 in level of 1. Two miRNAs derived from TE, hsa-miRNA-335 and -340 were related Neuroblastoma. The literature level evidence provided TF MYCN represses hsa-miRNA-335, and YAP1, RUNX1, and MYC activate hsa-miRNA-335 by level of 1. MYCN, RUNX1, and MYC activate hsa-miRNA-340 by level of 1.

From the list of human disease and cancer-related miRNAs derived from TE, numerically one of each miRNA was selected (hsa-miRNA-28, -181c, -224, -421, -548m, -625, -1294, -3144, -4662a, and -6503) to analyze by TransmiR v2.0. After all, it also provides correlation between numerous miRNA and TFs ([Figure 4](#life-10-00095-f004){ref-type="fig"}). Hsa-miRNA-28 is activated by various TFs, however, MYC represses hsa-miRNA-28 exclusively. Mostly, hsa-miRNA-28 was activated or repressed by TF and similarly, hsa-miRNA-181c was activated by many TFs. On the other hand, hsa-miRNA-181c was also activating abundant TFs. Additionally, RUNX1 and ETS1 represses and NFE2L2 regulates hsa-miRNA-181c. Hsa-miRNA-224 was activated by many TFs and it activates E2F1, EGR1, and KDM5B. TP53 represses and RELA activates or represses hsa-miRNA-224. Hsa-miRNA-421 was activated by most of related TFs, however MYCN regulates hsa-miRNA-421. Hsa-miRNA-548m is activated by GATA3, YAP1, and MAFK however, MYC represses hsa-miRNA-548m. Hsa-miRNA-625, -1294 is activated by abundant TFs and hsa-miRNA-625 activates several TFs. Hsa-miRNA-1294 also activates KMT2D, EP300, and MYC. Hsa-miRNA-3144 is activated by CHD2, SIN3A, GATA6, REST, TAF1, BRCA1, GATA3, MAX, ZBTB33, TBP, and CEBPB and hsa-miRNA-4662a is activated by CHD8, EOMES, MYC, NR1H3, and PPARG. Lastly, MEF2A, TEAD4, OTX2, MAFK, EP300, SPI1, STAT1, TRIM28, YAP1, and DDX5 activates hsa-miRNA-6503.

6. Discussion {#sec6-life-10-00095}
=============

Bioinformatics tools are useful and important when not much information is provided or studied for the target subjects. Numerous bioinformatics tools are provided online, and are ready to be used right away or downloaded. There are several bioinformatics tools of miRNAs, however, TE related bioinformatics tools are still insufficient. By using bioinformatics database related with TE, the distribution of TE has been modified ([Table 1](#life-10-00095-t001){ref-type="table"}) \[[@B15-life-10-00095]\]. The distribution of TE is highly scattered in the genome of most of the species. In the evolutionary aspects on distribution of TE, SVA element is exclusive in humans only. *Alu* element from SINE is a primate and mouse specific element excluding few mammalians (horse, cow, cat, and dog), chicken, zebrafish, and C. elegans. From LINE, the proportion of CR1 element is very low amongst all of mammalians, fish, and C. elegans, however, one study provided the evidence that CR1 element is moderately scattered in avian, crocodilian, turtle, and lepidosaurian, also known as diapsid reptiles \[[@B84-life-10-00095]\]. The distribution of ERVK from LTR element presents in primates until rhesus monkey, mouse and cow amongst the mammalians. Most of the ERVK studies are performed in primates, thus mouse shows highest of percentages of ERVK element among all the species, and one study mentioned that human and mouse contain numerous LTR-derived TFBS which contributes in other TFs to bind, and they did not mention the reason why mouse has a high percentage of ERVK element, yet it might be due to embryonic stem cells of mice \[[@B85-life-10-00095],[@B86-life-10-00095],[@B87-life-10-00095]\].

Approximately half of the genome is covered in TEs for mammalians and zebrafish, and over 10 percent for chicken and C. elegans and these highly distributed TEs are capable of generating miRNAs and TFBSs \[[@B30-life-10-00095],[@B31-life-10-00095],[@B34-life-10-00095],[@B87-life-10-00095]\]. Based on the miRNA studies, miRNAs derived from TE were filtered into two types, primate and evolution and human disease and cancer. [Table 2](#life-10-00095-t002){ref-type="table"} shows 51 of primate and evolution related miRNAs derived from TE and [Table 3](#life-10-00095-t003){ref-type="table"} shows 34 of human disease and cancer-related miRNAs derived from TE. First, to analyze miRNAs derived from TE related in primates and evolution, ECR browser was used to check the conservation on few of selected miRNAs derived from TE. The conservation is influential to miRNAs derived from TE related in primates and evolution due to selecting the target species or samples before going into the actual experiments. Previous studies checked the conservation of each target miRNAs they found to applicate them on primate and evolution related miRNAs \[[@B54-life-10-00095],[@B70-life-10-00095],[@B88-life-10-00095]\]. ECR browsers are used to predict the conservation of the target gene, miRNA, or the specific region of the genome. The conservation on few of the selected primate and evolution-related miRNAs derived from TE show conservation well until mammalians, however, few of miRNAs derived from TE are not randomly conserved ([Figure 2](#life-10-00095-f002){ref-type="fig"}). To examine the conservation precisely, the sequence of each miRNA is needed to be downloaded from each species. TargetScan database provides the sequences of conserved miRNAs in the target genes and this method is more accurate than the prediction from ECR browser \[[@B89-life-10-00095],[@B90-life-10-00095]\]. The RNAfold result predicts the strongness of base pairing as well as the MFE value of the miRNAs by the colors. The miRNA with the weakest structure is predicted as miRNA-1202.

The human disease and cancer related miRNAs derived from TE were analyzed with TFs. TransmiR database provides the information on TFBS that regulates or correlates with miRNAs. First, the examination of all 34 human disease and cancer related miRNAs derived from TE from [Table 3](#life-10-00095-t003){ref-type="table"} were analyzed to check the correlation between miRNAs derived from TE and TFs by human disease and cancer provided from TransmiR database ([Figure 3](#life-10-00095-f003){ref-type="fig"}). Four miRNAs derived from TE were found from three human disease and cancers provided from TransmiR. Other miRNA and TF studies used TransmiR to predict which TFs that their target miRNA is targeting or correlate together and applicate them on further bioinformatics analysis or experiments \[[@B91-life-10-00095],[@B92-life-10-00095]\]. In addition, few of TFs were determined on human disease and cancer related miRNAs derived from TE. As shown in [Figure 4](#life-10-00095-f004){ref-type="fig"}, some miRNAs derived from TE interact with numerous TFs and on the other hand, some miRNAs derived from TE interact with few TFs. The study of miRNA-548m and MYC supported the data of TransmiR based on the result of stroma-inducing miRNA-549m inhibition leads to the c-Myc overexpression \[[@B93-life-10-00095]\]. By using TransmiR databases, the hypothesis was suggested that enhancer activity of miRNAs derived from TE is increased by TFs, and the report actually mentioned that the enhancer activity of miRNAs derived from TE OF-miRNA-307 might induced by the TFs near OF-miRNA-307 binds in 3′UTR of target gene \[[@B94-life-10-00095]\].

The aim of this study was to introduce the basic bioinformatics tools used for TE and miRNAs derived from TE studies. The evolution and human disease-related miRNAs derived from TE were identified by published papers and they were analyzed with bioinformatics tools. Abundant miRNAs were derived from TEs and they have a close relation with primate and evolution and human disease and cancer. Here, fundamental information of miRNAs derived from TE by using several of the bioinformatics tools are analyzed.
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![Schematic step of analyzing microRNAs derived from transposable elements.](life-10-00095-g001){#life-10-00095-f001}

###### 

Result of ECR browser and RNAfold on evolution related miRNAs derived from transposable element. On top each miRNA derived from TE, the nearest gene is presented. Yellow represents the region of searched miRNA, green represents transposons and simple repeats, salmon represents intronic region, and red represents intergenic regions. The x-axis represents the position in the human genome and the y-axis represents the conservation scale compared with human. Underneath the ECR browser conservation figure, each RNAhold structure of miRNAs derived from TE is shown. The scale bar on the left shows the minimum free energy (MFE) value of strong and weakest base-pairing values from 0 to 1.
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![The analyses of human diseases related miRNAs derived from TE and transcription factors by TransmiR. For evidence level, level 1 and 2 is based on ChIP-seq data and level 2 is more stringent than level 1. The Literature level is based on the research papers. Other information is shown in the figure.](life-10-00095-g003){#life-10-00095-f003}

![The correlation of miRNAs derived from TE and transcription factors analyzed by TransmiR. For evidence level, level 1 and 2 are based on ChIP-seq data and level 2 is more stringent than level 1. The Literature level is based on the research papers. Other information is shown in the figure.](life-10-00095-g004){#life-10-00095-f004}

life-10-00095-t001_Table 1

###### 

The distribution of transposable elements in various species.

                  Human   Chimpanzee   Gorilla   Orangutan   Gibbon   Macaque   Rhesus   Marmoset   Mouse   Horse   Cow     Cat     Dog     Chicken   Zebrafish   *C. elegans*
  --------------- ------- ------------ --------- ----------- -------- --------- -------- ---------- ------- ------- ------- ------- ------- --------- ----------- --------------
  Non-TEs         47.5%   49.2%        50.6%     47.9%       48.1%    48.5%     50.7%    51.0%      55.0%   54.8%   50.6%   56.3%   56.8%   88.8%     47.4%       87.4%
  SINE/MIR        2.9%    2.9%         3.0%      2.9%        2.9%     2.9%      3.1%     2.7%       0.6%    3.8%    2.3%    3.1%    2.9%    0.0%      0.0%        0.0%
  SINE/Alu        10.5%   10.3%        8.8%      10.0%       10.4%    11.0%     10.5%    11.0%      4.8%    0.0%    0.0%    0.0%    0.0%    0.0%      0.0%        0.0%
  SINE/other      0.0%    0.0%         0.0%      0.0%        0.0%     0.0%      0.0%     0.0%       2.4%    3.7%    9.4%    8.3%    7.6%    0.0%      2.4%        0.0%
  SVA             0.1%    0.0%         0.0%      0.0%        0.0%     0.0%      0.0%     0.0%       0.0%    0.0%    0.0%    0.0%    0.0%    0.0%      0.0%        0.0%
  LINE/L2         3.7%    3.8%         3.8%      3.7%        3.8%     3.8%      4.0%     3.3%       0.4%    5.2%    2.7%    4.0%    3.7%    0.0%      1.7%        0.0%
  LINE/CR1        0.4%    0.4%         0.4%      0.4%        0.4%     0.4%      0.4%     0.4%       0.0%    0.6%    0.3%    0.4%    0.4%    6.8%      0.0%        0.3%
  LINE/RTE        0.2%    0.2%         0.2%      0.2%        0.2%     0.2%      0.2%     0.1%       0.0%    0.3%    12.9%   0.2%    0.2%    0.0%      0.2%        0.0%
  LINE/L1         17.5%   17.7%        16.8%     18.3%       17.4%    17.3%     15.5%    18.8%      19.9%   18.0%   13.3%   17.0%   16.8%   0.0%      0.4%        0.0%
  LINE/other      0.0%    0.0%         0.0%      0.0%        0.0%     0.0%      0.0%     0.0%       0.0%    0.0%    0.0%    0.0%    0.0%    0.0%      0.5%        0.0%
  LTR/ERVK        0.3%    0.3%         0.3%      0.3%        0.2%     0.4%      0.3%     0.0%       4.9%    0.0%    0.5%    0.0%    0.0%    0.0%      0.0%        0.0%
  LTR/ERV1        2.9%    2.8%         2.7%      2.9%        2.6%     2.7%      2.8%     2.2%       1.2%    1.9%    1.4%    1.0%    1.0%    0.2%      0.4%        0.0%
  LTR/ERVL        5.8%    5.9%         5.8%      5.9%        5.7%     5.8%      6.1%     5.2%       5.9%    5.0%    2.7%    4.0%    3.8%    1.3%      0.0%        0.0%
  LTR/Gypsy       0.2%    0.2%         0.2%      0.2%        0.2%     0.2%      0.2%     0.1%       0.0%    0.3%    0.0%    0.2%    0.2%    0.0%      1.7%        0.0%
  LTR/other       0.0%    0.0%         0.0%      0.0%        0.0%     0.0%      0.0%     0.0%       0.0%    0.2%    0.0%    0.0%    0.0%    0.0%      3.1%        0.3%
  DNA/TcMar       1.5%    1.5%         1.5%      1.5%        1.5%     1.5%      1.6%     1.3%       0.2%    0.8%    0.6%    0.8%    0.7%    0.3%      6.1%        1.8%
  DNA/hAT         2.2%    2.2%         2.2%      2.2%        2.2%     2.2%      2.3%     2.0%       0.9%    2.7%    1.6%    2.2%    2.1%    0.5%      9.7%        0.5%
  DNA/other       0.0%    0.0%         0.0%      0.0%        0.0%     0.0%      0.0%     0.0%       0.0%    0.0%    0.0%    0.0%    0.0%    0.2%      19.6%       6.1%
  Other/Unknown   4.3%    2.6%         3.7%      3.6%        4.4%     3.1%      2.3%     1.9%       3.8%    2.7%    1.7%    2.5%    3.8%    1.9%      6.8%        3.6%
  TOTAL: 100%                                                                                                                                                     

life-10-00095-t002_Table 2

###### 

The list of evolution related miRNAs derived from transposable element. The coordinates of miRNAs derived from transposable element (TE) in the human genome, the type and name of TE that miRNAs are derived from, and the references are shown in each column.

       microRNA     Coordinates                     Type of TE                            References
  ---- ------------ ------------------------------- ------------------------------------- -----------------------------------------------
  1    miR-28       chr3:188,688,781-188,688,866    LINE_L2c, L2c                         \[[@B53-life-10-00095],[@B55-life-10-00095]\]
  2    miR-130a     chr11:57,641,198-57,641,286     LINE_MamRTE1                          \[[@B55-life-10-00095]\]
  3    miR-151a     chr8:140,732,564-140,732,653    LINE_L2c, L2c                         \[[@B55-life-10-00095]\]
  4    miR-151b     chr14:100,109,419-100,109,514   LINE_L2b                              \[[@B53-life-10-00095],[@B55-life-10-00095]\]
  5    miR-224      chrX:151,958,578-151,958,658    DNA_MER135                            \[[@B53-life-10-00095]\]
  6    miR-302e     chr11:7,234,766-7,234,837       SINE_MIR                              \[[@B70-life-10-00095]\]
  7    miR-320d-1   chr13:40,727,816-40,727,887     LINE_L1MEd                            \[[@B53-life-10-00095],[@B55-life-10-00095]\]
  8    miR-342      chr14:100,109,655-100,109,753   SINE_MamSINE1                         \[[@B55-life-10-00095]\]
  9    miR-374a     chrX:74,287,286-74,287,357      LINE_L2c                              \[[@B53-life-10-00095]\]
  10   miR-378a     chr5:149,732,825-149,732,890    SINE_MIRc, MIRc                       \[[@B55-life-10-00095]\]
  11   miR-378b     chr3:10,330,229-10,330,285      SINE_MIR3, MIRc                       \[[@B54-life-10-00095],[@B55-life-10-00095]\]
  12   miR-378d-1   chr4:5,923,275-5,923,328        SINE_MIRb                             \[[@B54-life-10-00095],[@B55-life-10-00095]\]
  13   miR-378d-2   chr8:93,916,022-93,916,119      SINE_MIRc                             \[[@B54-life-10-00095],[@B55-life-10-00095]\]
  14   miR-378e     chr5:170,028,488-170,028,566    SINE_MIRb, MIRc                       \[[@B55-life-10-00095]\]
  15   miR-378f     chr1:23,929,070-23,929,147      SINE_MIRc                             \[[@B54-life-10-00095],[@B55-life-10-00095]\]
  16   miR-378h     chr5:154,829,458-154,829,540    SINE_MIRc                             \[[@B55-life-10-00095]\]
  17   miR-378i     chr22:41,923,222-41,923,297     SINE_MIRc                             \[[@B55-life-10-00095]\]
  18   miR-450b     chrX:134,540,185-134,540,262    LINE_L1ME4a                           \[[@B53-life-10-00095]\]
  19   miR-466      chr3:31,161,704-31,161,787      LINE_L1ME3                            \[[@B54-life-10-00095]\]
  20   miR-513a-1   chrX:147,213,463-147,213,591    DNA_MER91C                            \[[@B54-life-10-00095]\]
  21   miR-513a-2   chrX:147,225,826-147,225,952    DNA_MER91C                            \[[@B54-life-10-00095]\]
  22   miR-513b     chrX:147,199,044-147,199,127    DNA_MER91C                            \[[@B54-life-10-00095]\]
  23   miR-513c     chrX:147,189,704-147,189,787    DNA_MER91C                            \[[@B54-life-10-00095]\]
  24   miR-518d     chr19:53,734,877-53,734,963     LINE_MamRTE1                          \[[@B54-life-10-00095],[@B71-life-10-00095]\]
  25   miR-544a     chr14:101,048,658-101,048,748   DNA_MER5A1                            \[[@B54-life-10-00095]\]
  26   miR-544b     chr3:124,732,439-124,732,516    DNA_MER5A1                            \[[@B54-life-10-00095]\]
  27   miR-548a-1   chr6:18,571,784-18,571,880      DNA_MADE1                             \[[@B54-life-10-00095]\]
  28   miR-548a-2   chr6:135,239,160-135,239,256    LTR_LTR16A2, DNA_MADE1, LTR_LTR16A2   \[[@B54-life-10-00095]\]
  29   miR-570      chr3:195,699,401-195,699,497    DNA_MADE1                             \[[@B54-life-10-00095]\]
  30   miR-603      chr10:24,275,685-24,275,781     DNA_MADE1                             \[[@B56-life-10-00095]\]
  31   miR-619      chr12:108,836,908-108,837,006   LINE_L1MC4, SINE_AluSz6               \[[@B54-life-10-00095]\]
  32   miR-637      chr19:3,961,414-3,961,512       LINE_L1MC4a                           \[[@B57-life-10-00095]\]
  33   miR-652      chrX:110,055,329-110,055,426    DNA_MER91C                            \[[@B54-life-10-00095]\]
  34   miR-1202     chr6:155,946,797-155,946,879    LTR_MER52A                            \[[@B56-life-10-00095]\]
  35   miR-1261     chr11:90,869,121-90,869,202     DNA_Tigger1                           \[[@B54-life-10-00095]\]
  36   miR-1268a    chr15:22,225,278-22,225,329     SINE_AluJo                            \[[@B54-life-10-00095]\]
  37   miR-1268b    chr17:80,098,828-80,098,877     SINE_AluSx1                           \[[@B54-life-10-00095]\]
  38   miR-1273c    chr6:154,853,360-154,853,436    SINE_AluJo                            \[[@B54-life-10-00095]\]
  39   miR-1273h    chr16:24,203,116-24,203,231     SINE_AluJb                            \[[@B54-life-10-00095]\]
  40   miR-1302-1   chr12:112,695,034-112,695,176   DNA_MER54                             \[[@B54-life-10-00095]\]
  41   miR-1303     chr5:154,685,776-154,685,861    SINE_AluJr, FLAM_A                    \[[@B54-life-10-00095]\]
  42   miR-1304     chr11:93,733,674-93,733,764     SINE_AluJo                            \[[@B54-life-10-00095]\]
  43   miR-1587     chrX:39,837,561-39,837,613      LTR_MLT1H2                            \[[@B54-life-10-00095]\]
  44   miR-1972-1   chr16:15,010,321-15,010,397     SINE_AluSx, FLAM_A                    \[[@B54-life-10-00095]\]
  45   miR-2355     chr2:207,109,987-207,110,073    LINE_MamRTE1, MamRTE1                 \[[@B53-life-10-00095]\]
  46   miR-3118-1   chr21:13,644,775-13,644,850     LINE_L1PA12                           \[[@B54-life-10-00095]\]
  47   miR-3118-2   chr15:20,832,795-20,832,869     LINE_L1PA14                           \[[@B54-life-10-00095]\]
  48   miR-3118-3   chr15:21,406,385-21,406,459     LINE_L1PA13                           \[[@B54-life-10-00095]\]
  49   miR-3118-4   chr15:21,843,750-21,843,824     LINE_L1PA13                           \[[@B54-life-10-00095]\]
  50   miR-4452     chr4:86,542,482-86,542,552      SINE_AluJo                            \[[@B54-life-10-00095]\]
  51   miR-6303     chr10:24,275,685-24,275,781     DNA_MADE1                             \[[@B54-life-10-00095]\]
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###### 

The list of human disease related miRNAs derived from transposable element. The coordinates of miRNAs derived from TE in the human genome, the type and name of TE that miRNAs are derived from related disorders and the references are shown in each column.

       microRNA       Coordinates                     Type of TE              Related Disorders     References
  ---- -------------- ------------------------------- ----------------------- --------------------- -----------------------------------------------------------------------------------------
  1    miRNA-28       chr3:188,688,781-188,688,866    LINE_L2c, L2c           OC, M                 \[[@B74-life-10-00095]\]
  2    miRNA-95       chr4:8,005,301-8,005,381        LINE_L2b, L2c           OC, BrC               \[[@B74-life-10-00095]\]
  3    miRNA-130a     chr11:57,641,198-57,641,286     LINE_MamRTE1            LuC, OC, LiC          \[[@B46-life-10-00095],[@B48-life-10-00095],[@B75-life-10-00095],[@B76-life-10-00095]\]
  4    miRNA-151a     chr8:140,732,564-140,732,653    LINE_L2c                G, OC, BrC, M         \[[@B49-life-10-00095],[@B74-life-10-00095]\]
  5    miRNA-151b     chr14:100,109,419-100,109,514   LINE_L2b                OC, BrC, M            \[[@B74-life-10-00095]\]
  6    miRNA-181c     chr19:13,874,699-13,874,808     LINE_MamRTE1            LiC, A, OC, BrC       \[[@B74-life-10-00095],[@B77-life-10-00095]\]
  7    miRNA-224      chrX: 151,958,578-151,958,658   DNA_MER135              LiC                   \[[@B48-life-10-00095],[@B51-life-10-00095]\]
  8    miRNA-320d-1   chr13:40,727,816-40,727,887     LINE_L1MEd              OC, BrC, M, N         \[[@B47-life-10-00095],[@B48-life-10-00095],[@B74-life-10-00095]\]
  9    miRNA-335      chr7:130,496,111-130,496,204    SINE_MIRb               OC, M                 \[[@B74-life-10-00095]\]
  10   miRNA-340      chr5:180,015,303-180,015,397    DNA_MARNA               OC                    \[[@B74-life-10-00095]\]
  11   miRNA-342      chr14:100,109,655-100,109,753   SINE_MamSINE1           EC, ACC, PaC          \[[@B48-life-10-00095],[@B78-life-10-00095]\]
  12   miRNA-361      chrX: 85,903,636-85,903,707     DNA_MER5A               LuC                   \[[@B52-life-10-00095]\]
  13   miRNA-378a     chr5:149,732,825-149,732,890    SINE_MIRc, MIRc         BlC                   \[[@B49-life-10-00095]\]
  14   miRNA-378b     chr3:10,330,229-10,330,285      SINE_MIR3, MIRc         L                     \[[@B49-life-10-00095]\]
  15   miRNA-421      chrX:74,218,377-74,218,461      LINE_L2c, L2c           Ph, Pa                \[[@B49-life-10-00095]\]
  16   miRNA-513a-1   chrX:147,213,463-147,213,591    DNA_MER91C              LuC                   \[[@B79-life-10-00095]\]
  17   miRNA-513a-2   chrX:147,225,826-147,225,952    DNA_MER91C              LuC                   \[[@B79-life-10-00095]\]
  18   miRNA-518d     chr19:53,734,877-53,734,963     LINE_MamRTE1            LuC                   \[[@B79-life-10-00095]\]
  19   miRNA-545      chrX:74,287,104-74,287,209      LINE_L2c                LuC                   \[[@B79-life-10-00095]\]
  20   miRNA-546b     chr6:119,069,022-119,069,167    DNA_MADE1               LuC                   \[[@B79-life-10-00095]\]
  21   miRNA-548l     chr11:94,466,495-94,466,580     DNA_MADE1               LuC                   \[[@B79-life-10-00095]\]
  22   miRNA-548m     chrX:95,063,141-95,063,226      DNA_MADE1               LuC                   \[[@B79-life-10-00095]\]
  23   miRNA-625      chr14:65,471,102-65,471,186     LINE_L1MCa              M, GC, CoC, LuC, KC   \[[@B49-life-10-00095],[@B80-life-10-00095],[@B81-life-10-00095]\]
  24   miRNA-626      chr15:41,691,585-41,691,678     LINE_L1MB8, L1MB8       HPV                   \[[@B82-life-10-00095]\]
  25   miRNA-646      chr20:60,308,474-60,308,567     LTR_LTR67B              LuC                   \[[@B79-life-10-00095]\]
  26   miRNA-659      chr22:37,847,678-37,847,774     DNA_Arthur1B            D                     \[[@B77-life-10-00095]\]
  27   miRNA-1290     chr1:18,897,071-18,897,148      DNA_Tigger4a            LuC                   \[[@B79-life-10-00095]\]
  28   miRNA-1294     chr5:154,347,071-154,347,283    SINE_MIRb               LuC                   \[[@B79-life-10-00095]\]
  29   miRNA-2355     chr2:207,109,987-207,110,073    LINE_MamRTE1, MamRTE1   HPV                   \[[@B82-life-10-00095]\]
  30   miRNA-1304     chr11:93,733,674-93,733,764     SINE_AluJo              LuC, Pr, UCEC         \[[@B50-life-10-00095],[@B83-life-10-00095]\]
  31   miRNA-3144     chr6:120,015,179-120,015,257    LINE_L1MA8              LiC PrC, CeC, HPV     \[[@B82-life-10-00095],[@B83-life-10-00095]\]
  32   miRNA-3681     chr2:12,199,130-12,199,201      LTR_LTR16D1             CeC, LiC              \[[@B49-life-10-00095]\]
  33   miRNA-4662a    chr8:124,821,985-124,822,051    LINE_L1ME4b             LuC                   \[[@B49-life-10-00095]\]
  34   miRNA-6503     chr11:60,209,071-60,209,156     LINE_MLT1D              LiC, L                \[[@B49-life-10-00095],[@B83-life-10-00095]\]

Abbreviations: Ovarian cancer (OC), Melanoma (M), Breast cancer (BrC), Lung cancer (LuC), Glioblastoma (G), Alzheimer (A), Neuroblastoma (N), Endocrine cancer (EC), Acrinar cell carcinoma (ACC), Pancreatic cancer (PaC), Bladder cancer (BlC), Leukemia (L), Pheochromocytoma (Ph), Paraganglioma (Pa), Gastric cancer (GC), Colorectal cancer (CoC), Kidney cancer (KC), Human papillomavirus (HPV), Dementia (D), Preeclampsia (Pr), Uterine Corpus Endometrial Carcinoma (UCEC), Prostate cancer (PrC), Cervical cancer (CeC), Liver cancer (LiC).
